Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2010
12/07/2010US7846427 Stabilized interferon liquid formulations
12/07/2010CA2592605C Method for stabilizing anti-dementia drug
12/07/2010CA2552318C Composition for combating ectoparasites and their ova
12/07/2010CA2462637C Timed, sustained release multi-particulate dosage forms of propranolol
12/07/2010CA2461659C Modified release dosage forms
12/07/2010CA2456029C Stable emulsion composition
12/07/2010CA2453263C Pharmaceutical compositions containing terbinafine and use thereof
12/07/2010CA2425199C Formulation of substituted benzimidazoles
12/07/2010CA2406261C Antiinflammatory-containing plaster
12/07/2010CA2394622C Stabilisation of pigments and polyunsaturated oils and oil concentrates
12/07/2010CA2386339C Dip coating compositions containing cellulose ethers
12/07/2010CA2326720C Hemoglobin-haptoglobin complexes
12/07/2010CA2299522C Diluting and disintegrating composition, method for obtaining same and use thereof
12/07/2010CA2153653C Growth differentiation factor-9
12/02/2010WO2010138797A1 Peptoid ligands for isolation and treatment of autoimmune t-cells
12/02/2010WO2010138660A1 Anticancer pharmaceutical formulation
12/02/2010WO2010138519A2 Use of adsorbent carbon microspheres for the treatment of pruritus
12/02/2010WO2010138395A2 Methods of treating chronic neurogenic inflammation using glucagon like hormone retargeted endopepidases
12/02/2010WO2010138393A2 Methods of treating urogenital-neurological disorders using glucagon like hormone retargeted endopepidases
12/02/2010WO2010138392A2 Methods of treating chronic neurogenic inflammation using neurotrophin retargeted endopepidases
12/02/2010WO2010138389A2 Methods of treating urogenital-neurological disorders using neurotrophin retargeted endopepidases
12/02/2010WO2010138387A2 Methods of treating chronic neurogenic inflammation using interleukin retargeted endopepidases
12/02/2010WO2010138384A2 Methods of treating urogenital-neurological disorders using interleukin retargeted endopeptidases
12/02/2010WO2010138382A1 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin
12/02/2010WO2010138379A2 Methods of treating chronic neurogenic inflammation using galanin retargeted endopeptidases
12/02/2010WO2010138366A2 Methods of treating urogenital-neurological disorders using galanin retargeted endopepidases
12/02/2010WO2010138194A2 Immunomodulatory agent-polymeric compounds
12/02/2010WO2010138193A2 Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents
12/02/2010WO2010138192A2 Nanocarriers possessing components with different rates of release
12/02/2010WO2010138099A1 Dermal medicament delivery system causing an exothermic reaction
12/02/2010WO2010138074A1 Hyaluronic acid based delivery systems
12/02/2010WO2010138064A1 Aqueous film coating composition
12/02/2010WO2010137888A2 Microspheres with improved bioavailability containing poorly water-soluble drugs, and method for preparing same
12/02/2010WO2010137716A1 Orally disintegrating tablet which contains precipitated calcium carbonate as active ingredient
12/02/2010WO2010137699A1 Patch material
12/02/2010WO2010137696A1 Oral medicinal composition and oral medicinal capsule having the composition encapsulated therein
12/02/2010WO2010137613A1 Solid preparation having improved storage stability
12/02/2010WO2010137570A1 Anti-viral agent or an anti-cancer agent
12/02/2010WO2010137335A1 TURN-OVER-ACCELERATING COMPOSITION CONTAINING α-LIPOIC ACID NANOPARTICLES
12/02/2010WO2010137122A1 Collagen production enhancer
12/02/2010WO2010137027A1 Solid oral dosage forms of lamivudine
12/02/2010WO2010137012A1 Peptide therapy for amphiregulin mediated diseases
12/02/2010WO2010136947A1 Liposome based diepitope constructs
12/02/2010WO2010136739A2 Controlled-release floating pharmaceutical compositions
12/02/2010WO2010136585A2 Combination of adrenergic receptor agonist -1 or -2, preferably brimonidine with fillers, preferablyhyaluronic acid
12/02/2010WO2010136487A1 Albumin-amyloid peptide conjugates and uses thereof
12/02/2010WO2010136480A1 Antigen-binding proteins
12/02/2010WO2010136242A1 Bonding products of aminated polysaccharides
12/02/2010WO2010136149A1 Transdermal therapeutic system having controlled active substance flow comprising a basic reacting oxide
12/02/2010WO2010110916A3 Determination of tracers within subjects
12/02/2010WO2010109212A3 Carrier comprising a vitamin e derivative
12/02/2010WO2010103017A3 Hapten-carrier conjugates with bacterial toxins having a signal peptide as carrier and their use in immunogenic compositions
12/02/2010WO2010095978A3 Method for preparing a proinsulin preparation for peroral use
12/02/2010WO2010091192A3 Nanoscale platinum compounds and methods of use thereof
12/02/2010WO2010078945A3 Cancer treatment
12/02/2010WO2010014258A3 Conjugates having a releasable linkage
12/02/2010WO2010013136A3 Active particles for bio-analytical applications and methods for their preparation
12/02/2010WO2009154304A3 A pharmaceutical composition comprising rebamipide
12/02/2010WO2009133545A3 Vascular delivery systems
12/02/2010WO2000045847A8 Novel mucosal delivery system
12/02/2010US20100305218 Nanoemulsions
12/02/2010US20100305217 High performance membrane
12/02/2010US20100305208 Gastric retention controlled drug delivery system
12/02/2010US20100305191 Rna interference mediated inhibition of adenosine a1 receptor (adora1) gene expression using short interfering rna
12/02/2010US20100305179 Oral sustained-release tablet
12/02/2010US20100305178 Pharmaceutical Composition
12/02/2010US20100305147 Chemically modified small molecules
12/02/2010US20100305081 Organo-gel formulations for therapeutic applications
12/02/2010US20100305045 Omega-3 oil containing ophthalmic emulsions
12/02/2010US20100305032 Novel GLP-1 Derivatives
12/02/2010US20100304974 Volumizing agents
12/02/2010US20100303929 Compounds and methods for treating cancer
12/02/2010US20100303920 Aqueous Film Coating Composition / 841
12/02/2010US20100303900 Preparation of injectable suspensions having improved injectability
12/02/2010US20100303815 METHOD OF TREATING ANEMIA BY ADMINISTERING IL 1ra
12/02/2010US20100303797 Use of p97 As An Enzyme Delivery System For The Delivery of Therapeutic Lysosomal Enzymes
12/02/2010US20100303743 Personal Care Compositions Containing Hydrophobic Silicone-Organic Gel Blends
12/02/2010US20100303740 Process for producing (3s)-i-menthyl 3-hydroxybutyrate and sensate composition
12/02/2010US20100303736 Anti-il-9 antibody formulations and uses thereof
12/02/2010US20100303726 Humanized collagen antibodies and related methods
12/02/2010US20100303718 Stabilized Uncoated Particles of Reversed Liquid Crystalline Phase Materials
12/02/2010CA2763685A1 Peptoid ligands for isolation and treatment of autoimmune t-cells
12/02/2010CA2763569A1 Albumin-amyloid peptide conjugates and uses thereof
12/02/2010CA2763539A1 Controlled-release floating pharmaceutical compositions
12/02/2010CA2763465A1 A poorly soluble drug containing microsphere with improved bioavailability and method of preparing the same
12/02/2010CA2763439A1 Antigen-binding proteins
12/02/2010CA2763365A1 Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the same
12/02/2010CA2763320A1 Oral medical composition and oral medical capsule enclosing the same
12/02/2010CA2762877A1 Polyal drug conjugates comprising variable rate-releasing linkers
12/02/2010CA2762653A1 Immunomodulatory agent-polymeric compounds
12/02/2010CA2762650A1 Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents
12/02/2010CA2762647A1 Nanocarriers possessing components with different rates of release
12/02/2010CA2761283A1 Combination of adrenergic receptor agonist .alpha.-1 or .alpha.-2, preferably brimonidine with fillers, preferablyhyaluronic acid
12/02/2010CA2755829A1 Bonding products of aminated polysaccharides
12/01/2010EP2256191A1 Cyclic single-stranded nucleic acid complex and method for producing the same
12/01/2010EP2256134A1 IgG Fc fragment for a drug carrier and method for the preparation thereof
12/01/2010EP2255831A1 Liposome based diepitope constructs
12/01/2010EP2255812A1 Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
12/01/2010EP2255809A1 Medicated patch
12/01/2010EP2255806A2 Fentanyl composition for nasal administration
1 ... 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 ... 1712